MILAN — At the ESCRS meeting, Magda Rau, MD, speaks about the new Jett Plasma treatment from Compex for blepharitis and dry eye disease.
Through the emission of plasma, the device revitalizes the cells, softens the content of the meibomian glands and reduces the release of proinflammatory factors. A study showed significant reduction of dry eye signs and symptoms and increased subjectively reported patient comfort.